Clinical Trial Update: A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Clinical trial update reporting the completion of a Phase 1 study evaluating the safety and tolerability of LY3938577 in healthy participants and in individuals…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY3938577

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED